Company research / JAZZ
Jazz Pharmaceuticals plc (JAZZ)
- Sector Manufacturing
- Incorporated L2
- Fiscal year ends Dec 31
For the year ended 2025-12-31, Jazz Pharmaceuticals plc reported revenue of $4.27B. Revenue grew 4.9% from the prior annual period.
Key ratios (year ended 2025-12-31)
-10.1%
Operating margin
-8.3%
Net margin
-8.2%
Return on year-end equity
4.9%
Revenue growth (YoY)
Beyond the statements
Follow the company.
Explore new filings, reported insider transactions and company relationships.